Baltimore, Sunogel Biotechnologies, Inc. (“Sunogel” or “the Company”), a leader in deep dermal wound healing research, committed to scientific excellence and patient care wins third prize at the IUIA Washington Startup Competition.

Dr Guoming Sun, Chief Executive Officer of Sungel, commented:

“Winning third prize at the IUIA Washington Startup Competition is great recognition for all our hard work. We believe the goal of regenerating perfect skin is within our reach. The amount of interest we have received not only validates our research but also further highlights the urgent unmet need in patient care our technology addresses.”